21SW23 - Naturopathic Considerations for Musculoskeletal Pain terpenes FDA Good Manufacturing Practices (GMPs)

FDA Good Manufacturing Practices (GMPs) and the Community Herbalist

Clinical Management of Cardiovascular Cases with Botanical Medicine 135 David Winston

Botanical Alternatives to Common Pharmaceuticals

Botanical Medicine for Infants and Toddlers

Speaker: Lise Alschuler Continued from Part 1

21SW23 - Naturopathic Considerations for Musculoskeletal Pain terpenes FDA Good Manufacturing Practices (GMPs)Speaker: Kenneth Proefrock, NMD Physical pain is the most common reason for patients to seek medical attention. It is also the most common reason for them to continue seeking medical attention when the usual routes of pharmaceutical intervention fail them. If a drug is able to resolve one's pain in the moment, it seldom addresses the reasons for that pain and is unable to keep the pain away without successively stronger dosages, until, eventually, the